Submitted by Anonymous (not verified) on 7 October 2026 - 15:28
Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 33, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 33, Status: Authorised